LEADER 00940nam0-22003011i-450-
001 990008499160403321
005 20071001101348.0
010   $a0-89004-955-6
035   $a000849916
035   $aFED01000849916
035   $a(Aleph)000849916FED01
035   $a000849916
100   $a20070405d1984----km-y0itay50------ba
101 0 $aeng
200 1 $aEnd points for cardiovascular drug studies$fRuth Johnsson Hegyeli, editor
210   $aNew York$cRaven Press$dc1984
215   $aXIII, 200 p.$cill.$d24 cm
225 1 $aAtherosclerosis reviews$v12
610 0 $aAterosclerosi$aCongressi
610 0 $aApparato cardiovascolare$aTerapia farmacologica$aCongressi
702  1$aHegyeli,$bRuth Johnsson
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008499160403321
952   $a616.13-004.6 END/D$b911$fDMECM
959   $aDMECM
996   $aEnd points for cardiovascular drug studies$9731760
997   $aUNINA